OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine
Yuan Liu, Ziwen Tong, Jingru Shi, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Bacterial proton motive force as an unprecedented target to control antimicrobial resistance
Bingqing Yang, Ziwen Tong, Jingru Shi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1068-1090
Closed Access | Times Cited: 47

Vancomycin Resistance in Enterococcus and Staphylococcus aureus
Gen Li, Mark J. Walker, David M. P. De Oliveira
Microorganisms (2022) Vol. 11, Iss. 1, pp. 24-24
Open Access | Times Cited: 67

The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
Jingru Shi, Chen Chen, Dejuan Wang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 51

Call for next-generation drugs that remove the uptake barrier to combat antibiotic resistance
Bo Peng, Hui Li, Xuan‐xian Peng
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103753-103753
Closed Access | Times Cited: 23

Copper(II) enhances the antibacterial activity of nitroxoline against MRSA by promoting aerobic glycolysis
Xiaoyong Huang, Huiting Yang, Xiaomin Ren, et al.
Biophysical Chemistry (2025) Vol. 320-321, pp. 107419-107419
Closed Access

Daunorubicin resensitizes Gram-negative superbugs to the last-line antibiotics and prevents the transmission of antibiotic resistance
Jinju Cai, Tian Deng, Jingru Shi, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106809-106809
Open Access | Times Cited: 11

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
Chen Chen, Jinju Cai, Jingru Shi, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 11

Restoring tigecycline efficacy with lysine supplementation in tmexCD-toprJ-positive bacteria
Fulei Li, Tianqi Xu, Dan Fang, et al.
International Journal of Antimicrobial Agents (2025), pp. 107511-107511
Closed Access

Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria
Tian Deng, Yuqian Jia, Ziwen Tong, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 17

Cinnamaldehyde targets SarA to enhance β‐lactam antibiotic activity against methicillin‐resistant Staphylococcus aureus
Jianguo Li, Ting-Yin Lu, Yue-Fei Chu, et al.
mLife (2024) Vol. 3, Iss. 2, pp. 291-306
Open Access | Times Cited: 3

Targeting the phosphatidylglycerol lipid: An amphiphilic dendrimer as a promising antibacterial candidate
N Zhang, Dinesh Dhumal, Shanny Hsuan Kuo, et al.
Science Advances (2024) Vol. 10, Iss. 39
Open Access | Times Cited: 3

Repurposing the Hedgehog pathway inhibitor, BMS-833923, as a phosphatidylglycerol-selective membrane-disruptive colistin adjuvant against ESKAPE pathogens
Nian Zhang, Wenying Shan, Liangliang Gao, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106888-106888
Closed Access | Times Cited: 7

Repurposing Anthracycline Drugs as Potential Antibiotic Candidates and Potentiators to Tackle Multidrug-Resistant Pathogens
Jingru Shi, Chen Chen, Miao Zhang, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 2, pp. 594-605
Closed Access | Times Cited: 2

Antibacterial activity of isopropoxy benzene guanidine against Riemerella anatipestifer
Yixing Lu, Weimei Qiao, Yaqian Xue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Non-antibiotic pharmaceuticals are toxic against Escherichia coli with no evolution of cross-resistance to antibiotics
Rebecca J Hall, Ann E. Snaith, Sarah J. Element, et al.
npj Antimicrobials and Resistance (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2

New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations
Sebastian G. Wicha, Annabelle Walz, Mohammed H. Cherkaoui‐Rbati, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 11
Open Access | Times Cited: 12

Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance
Zsuzsanna Schelz, Hiba F. Muddather, István Zupkó
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1468-1468
Open Access | Times Cited: 6

Famotidine Enhances Rifampicin Activity against Acinetobacter baumannii by Affecting OmpA
Mengna Zhang, Xiaoou Zhao, Qi Cui, et al.
Journal of Bacteriology (2023) Vol. 205, Iss. 8
Open Access | Times Cited: 5

An optimized antimicrobial peptide analog acts as an antibiotic adjuvant to reverse methicillin-resistant Staphylococcus aureus
Xuan Chen, Xiaoping Wu, Shaoyun Wang
npj Science of Food (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 8

The effect of topical drugs on the course of ARVI in children in modern conditions
Т. А. Руженцова, Александр Гарбузов, Н. А. Мешкова, et al.
Immunopathology Allergology Infectology (2024), pp. 86-92
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top